Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 14/20 | 0.68 |
| ▸ | CDK4 | P11802 | 10/20 | 0.68 |
| ▸ | SYK | P43405 | 6/20 | 0.56 |
| ▸ | SRC | P12931 | 3/20 | 0.56 |
| ▸ | ZAP70 | P43403 | 3/20 | 0.56 |
| ▸ | PLK1 | P53350 | 4/20 | 0.55 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.55 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.54 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.54 |
| ▸ | CDK1 | P06493 | 2/20 | 0.54 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.54 |
| ▸ | CDK7 | P50613 | 2/20 | 0.54 |
| ▸ | CDK9 | P50750 | 2/20 | 0.54 |
| ▸ | CCNH | P51946 | 2/20 | 0.54 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4391357 | 0.86 | CDK2 (0.68) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL4383709 | 0.85 | CDK2 (0.65) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL14378999 | 0.85 | CDK2 (0.64) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL14008738 | 0.84 | CDK2 (0.51) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL4385809 | 0.83 | AURKA (0.58) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL4386032 | 0.82 | CDK2 (0.72) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL14216016 | 0.81 | ZAP70 (0.72) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL14216178 | 0.81 | SYK (0.70) | CDK2CDK4SYKSRCZAP70 | |
| SCHEMBL29644961 | 0.81 | CDK2 (1.00) | CDK2CDK4PLK1AURKBCDK1 | |
| SCHEMBL2285895 | 0.81 | CDK2 (1.00) | CDK2CDK4PLK1AURKBCDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1751146-B1 | PYRIDINYL- OR PYRIMIDINYL THIAZOLES WITH PROTEIN KINASE INHIBITING ACTIVITY | CYCLACEL LTD (GB) | 2009-12-02 | — | — | EP | claimed |
| US-20080318954-A1 | Compounds | CYCLACEL LIMITED (GB) | 2008-12-25 | — | — | US | claimed |
| CN-1914199-A | Pyridyl or pyrimidyl thiazole compounds having protein kinase inhibitory activity | CYCLACEL LTD (GB) | 2007-02-14 | — | — | CN | claimed |
| EP-1751146-B1 | PYRIDINYL- OR PYRIMIDINYL THIAZOLES WITH PROTEIN KINASE INHIBITING ACTIVITY | CYCLACEL LTD (GB) | 2009-12-02 | — | — | EP | disclosed |
| EP-1751146-B1 | PYRIDINYL- OR PYRIMIDINYL THIAZOLES WITH PROTEIN KINASE INHIBITING ACTIVITY | CYCLACEL LTD (GB) | 2009-12-02 | — | — | EP | disclosed |
| US-20080318954-A1 | Compounds | CYCLACEL LIMITED (GB) | 2008-12-25 | — | — | US | disclosed |
| US-20080318954-A1 | Compounds | CYCLACEL LIMITED (GB) | 2008-12-25 | — | — | US | disclosed |
| US-20080318954-A1 | Compounds | CYCLACEL LIMITED (GB) | 2008-12-25 | — | — | US | disclosed |
| CN-1914199-A | Pyridyl or pyrimidyl thiazole compounds having protein kinase inhibitory activity | CYCLACEL LTD (GB) | 2007-02-14 | — | — | CN | disclosed |
| WO-2005075468-A2 | PYRIDINYL - OR PYRIMIDINYL THIAZOLES WITH PROTEIN KINASE INHIBITING ACTIVITY | CYCLACEL LIMITED (GB) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318954-A1 | Compounds | CBR3, NR3C2, NR5A1 | CDK2 1186/4885CDK4 607/4885SYK 3919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.